The University of Chicago Header Logo

Connection

Paul Vezina to Nucleus Accumbens

Back to Details
This is a "connection" page, showing publications Paul Vezina has written about Nucleus Accumbens.
Paul Vezina
Connection Strength
10.248
Nucleus Accumbens
  1. Maladaptive consequences of repeated intermittent exposure to uncertainty. Prog Neuropsychopharmacol Biol Psychiatry. 2020 04 20; 99:109864.
    View in: PubMed
    Score: 0.637
  2. Exposure to conditions of uncertainty promotes the pursuit of amphetamine. Neuropsychopharmacology. 2019 01; 44(2):274-280.
    View in: PubMed
    Score: 0.568
  3. Operant responding for optogenetic excitation of LDTg inputs to the VTA requires D1 and D2 dopamine receptor activation in the NAcc. Behav Brain Res. 2017 08 30; 333:161-170.
    View in: PubMed
    Score: 0.533
  4. Sensitizing exposure to amphetamine increases AMPA receptor phosphorylation without increasing cell surface expression in the rat nucleus accumbens. Neuropharmacology. 2017 05 01; 117:328-337.
    View in: PubMed
    Score: 0.521
  5. Drug-Paired Contextual Stimuli Increase Dendritic Spine Dynamics in Select Nucleus Accumbens Neurons. Neuropsychopharmacology. 2016 07; 41(8):2178-87.
    View in: PubMed
    Score: 0.488
  6. Inhibiting cyclin-dependent kinase 5 in the nucleus accumbens enhances the expression of amphetamine-induced locomotor conditioning. Behav Brain Res. 2014 Dec 15; 275:96-100.
    View in: PubMed
    Score: 0.439
  7. Locomotor conditioning by amphetamine requires cyclin-dependent kinase 5 signaling in the nucleus accumbens. Neuropharmacology. 2014 Oct; 85:243-52.
    View in: PubMed
    Score: 0.431
  8. Persistent reversal of enhanced amphetamine intake by transient CaMKII inhibition. J Neurosci. 2013 Jan 23; 33(4):1411-6.
    View in: PubMed
    Score: 0.392
  9. Casein kinase 1 enables nucleus accumbens amphetamine-induced locomotion by regulating AMPA receptor phosphorylation. J Neurochem. 2011 Jul; 118(2):237-47.
    View in: PubMed
    Score: 0.350
  10. Dorsal as well as ventral striatal lesions affect levels of intravenous cocaine and morphine self-administration in rats. Neurosci Lett. 2011 Apr 08; 493(1-2):29-32.
    View in: PubMed
    Score: 0.343
  11. Transient viral-mediated overexpression of alpha-calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell leads to long-lasting functional upregulation of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors: dopamine type-1 receptor and protein kinase A dependence. Eur J Neurosci. 2010 Apr; 31(7):1243-51.
    View in: PubMed
    Score: 0.322
  12. Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine. J Neurosci. 2010 Jan 20; 30(3):939-49.
    View in: PubMed
    Score: 0.319
  13. The PKC inhibitor Ro31-8220 blocks acute amphetamine-induced dopamine overflow in the nucleus accumbens. Neurosci Lett. 2009 May 15; 455(2):88-92.
    View in: PubMed
    Score: 0.300
  14. Amphetamine-induced changes in dendritic morphology in rat forebrain correspond to associative drug conditioning rather than nonassociative drug sensitization. Biol Psychiatry. 2009 May 15; 65(10):835-40.
    View in: PubMed
    Score: 0.298
  15. Inhibition of CaMKII in the nucleus accumbens shell decreases enhanced amphetamine intake in sensitized rats. Neurosci Lett. 2008 Oct 24; 444(2):157-60.
    View in: PubMed
    Score: 0.288
  16. Blockade of group II metabotropic glutamate receptors in the nucleus accumbens produces hyperlocomotion in rats previously exposed to amphetamine. Neuropharmacology. 2006 Oct; 51(5):986-92.
    View in: PubMed
    Score: 0.251
  17. Previous exposure to psychostimulants enhances the reinstatement of cocaine seeking by nucleus accumbens AMPA. Neuropsychopharmacology. 2004 Dec; 29(12):2149-59.
    View in: PubMed
    Score: 0.223
  18. Microinjection of CART peptide 55-102 into the nucleus accumbens blocks amphetamine-induced locomotion. Neuropeptides. 2003 Dec; 37(6):369-73.
    View in: PubMed
    Score: 0.208
  19. Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow. Neuropharmacology. 2003 Jan; 44(1):102-10.
    View in: PubMed
    Score: 0.195
  20. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens. Synapse. 2002 Sep 01; 45(3):159-70.
    View in: PubMed
    Score: 0.191
  21. Group II, but not group I, metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. Neuropharmacology. 2000 Jul 24; 39(10):1692-9.
    View in: PubMed
    Score: 0.165
  22. Mesoaccumbens dopamine and the self-administration of amphetamine. Ann N Y Acad Sci. 1999 Jun 29; 877:820-2.
    View in: PubMed
    Score: 0.153
  23. Blockade of glutamate reuptake in the rat nucleus accumbens increases locomotor activity. Brain Res. 1999 Feb 20; 819(1-2):165-9.
    View in: PubMed
    Score: 0.149
  24. Depletion of dopamine in the nucleus accumbens prevents the generation of locomotion by metabotropic glutamate receptor activation. Brain Res. 1998 Nov 23; 812(1-2):260-4.
    View in: PubMed
    Score: 0.147
  25. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. J Pharmacol Exp Ther. 1998 Jan; 284(1):317-22.
    View in: PubMed
    Score: 0.138
  26. The metabotropic glutamate receptor antagonist (RS)-MCPG produces hyperlocomotion in amphetamine pre-exposed rats. Neuropharmacology. 1998; 37(2):189-97.
    View in: PubMed
    Score: 0.138
  27. Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner. J Pharmacol Exp Ther. 1997 Nov; 283(2):962-8.
    View in: PubMed
    Score: 0.137
  28. Leptin in the nucleus accumbens core disrupts acute cocaine effects: Implications for GSK3ß connections. Behav Brain Res. 2018 Jan 30; 337:46-52.
    View in: PubMed
    Score: 0.136
  29. Cocaine inhibits leptin-induced increase of the cocaine- and amphetamine-regulated transcript peptide in the nucleus accumbens in rats. Neuroreport. 2017 Aug 02; 28(11):701-704.
    View in: PubMed
    Score: 0.134
  30. Stimuli associated with the presence or absence of amphetamine regulate cytoskeletal signaling and behavior. Eur Neuropsychopharmacol. 2016 11; 26(11):1836-1842.
    View in: PubMed
    Score: 0.127
  31. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther. 1994 Aug; 270(2):690-6.
    View in: PubMed
    Score: 0.109
  32. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens. Synapse. 1994 Feb; 16(2):104-12.
    View in: PubMed
    Score: 0.105
  33. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 1993 Mar 12; 605(2):332-7.
    View in: PubMed
    Score: 0.099
  34. Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug. Eur J Neurosci. 2013 Mar; 37(6):1004-11.
    View in: PubMed
    Score: 0.098
  35. a-1 Adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission. Neuropsychopharmacology. 2012 Aug; 37(9):2161-72.
    View in: PubMed
    Score: 0.094
  36. Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens. J Neurophysiol. 2011 Aug; 106(2):801-8.
    View in: PubMed
    Score: 0.087
  37. Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine. J Pharmacol Exp Ther. 2011 Jun; 337(3):724-33.
    View in: PubMed
    Score: 0.086
  38. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res. 1990 May 14; 516(1):99-106.
    View in: PubMed
    Score: 0.081
  39. A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior. Brain Res. 1988 Aug 09; 457(2):287-94.
    View in: PubMed
    Score: 0.072
  40. Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment. Behav Brain Res. 2008 Aug 05; 191(1):62-6.
    View in: PubMed
    Score: 0.070
  41. Exposure to nicotine and sensitization of nicotine-induced behaviors. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15; 31(8):1625-38.
    View in: PubMed
    Score: 0.067
  42. Sensitization, drug addiction and psychopathology in animals and humans. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15; 31(8):1553-5.
    View in: PubMed
    Score: 0.067
  43. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res. 1987 Aug 04; 417(1):51-8.
    View in: PubMed
    Score: 0.067
  44. Activation of group II mGlu receptors blocks the enhanced drug taking induced by previous exposure to amphetamine. Eur J Neurosci. 2005 Jan; 21(1):295-300.
    View in: PubMed
    Score: 0.056
  45. Glutamate inputs from the laterodorsal tegmental nucleus to the ventral tegmental area are essential for the induction of cocaine sensitization in male mice. Psychopharmacology (Berl). 2022 Oct; 239(10):3263-3276.
    View in: PubMed
    Score: 0.048
  46. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci. 2002 Jun 01; 22(11):4654-62.
    View in: PubMed
    Score: 0.047
  47. Conditioned inhibition of amphetamine sensitization. Neurobiol Learn Mem. 2022 07; 192:107636.
    View in: PubMed
    Score: 0.047
  48. Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited. J Neurosci. 2001 Mar 01; 21(5):RC133.
    View in: PubMed
    Score: 0.043
  49. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area. Psychopharmacology (Berl). 2000 Aug; 151(2-3):184-91.
    View in: PubMed
    Score: 0.041
  50. Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule. Behav Brain Res. 2000 Jan; 107(1-2):9-19.
    View in: PubMed
    Score: 0.040
  51. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci. 1996 Apr 01; 16(7):2411-20.
    View in: PubMed
    Score: 0.031
  52. Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat. Neurosci Lett. 1994 Feb 28; 168(1-2):111-4.
    View in: PubMed
    Score: 0.026
  53. Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol. 2009 Oct 01; 78(7):756-65.
    View in: PubMed
    Score: 0.019
  54. A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology (Berl). 2009 May; 203(4):703-11.
    View in: PubMed
    Score: 0.018
  55. Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci. 1994 Mar 01; 6(3):293-8.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.